Alzheimer's disease

Simple lifestyle interventions are a tempting target to stave off cognitive decline and Alzheimer's disease. Sadly, two new studies appearing in JAMA show no discernible benefit from exercise activity nor from omega-3 or vitamin supplementation.
Preliminary reports out of the Alzheimer s Association International Conference, which is happening this week in DC, give some inklings of hope against this intractable, soul-robbing disease. Without progress, millions are predicted to gradually fade away.
ACSH medical director Dr. Gilbert Ross and ACSH friend, the Hoover Institution s Dr. Henry Miller, have taken to Forbes.com to discuss the current state of Alzheimer s disease (AD) in our country. The article imparts a thorough discussion on the state of diagnostics, treatment and research of a disease whose prevalence is on the rise in America. The writers point out that in comparison with higher profile diseases (such as heart dis
Two large meta-analyses in JAMA shed light on the link between Alzheimer s disease and amyloid beta (A-β). The key findings indicate that it is likely to take up to 30 years of amyloid deposition before clear signs of dementia are manifest but such deposits are not diagnostic.
Snoring (sleep-disordered breathing, SDB) and cognitive decline linked in a new study. Does one cause the other? This study cannot tell us, and it s a stretch to figure out how that might work. Confounders, data-dredging also likely.
A simple set of tests may increase our ability to predict Alzheimer s type dementia. Why is this important? We must have reliable early predictors to do the tests that will eventually yield a prevention or treatment.
A group of researchers from Umea University in Sweden published two related studies in their attempt to explore a link between infection
For the first time, researchers created what they call Alzheimer s in a Dish human brain cells that develop defining Alzheimer s structures in a petri dish. This incredible achievement could redefine how Alzheimer s and potential treatment drugs are studied. Until now, researchers were only able to use mice that developed an imperfect form of the disease.
The National Center for Health Statistics released their annual report on mortality last week, and not so surprisingly, they found that the life expectancy in 2012 for older adults has continued to increase. Currently, a 65 year old will live on an average an additional 19.3 years: about 18 years for men and almost 21 years for
The latest in health news: a new cancer drug prolongs life, an FDA-approved device could be key in distinguishing between cognitive impairment and Alzheimer's disease, and why heart attacks may look very different in women
Recently, the FDA has approved new PET tracers as clinical tools to estimate brain amyloid burden in patients being evaluated for cognitive impairment or dementia. And these new tracers - tau-protein tracers - may be
Hypertension is well-known to be a major risk factor for all types of cardiovascular disease: stroke and heart attack. Now a study seems to show that mid-life HT may also predict cognitive decline later on.